Technology

BELKIN Vision is developing an accessible laser procedure for the primary treatment of glaucoma by means of a simple treatment applied in seconds.

What is Glaucoma?
Glaucoma is a disease that damages the eye’s optic nerve. It usually happens when fluid builds up in the front part of the eye. The extra fluid increases the pressure in the eye, damaging the optic nerve. The only treatment for glaucoma and ocular hypertension (OHT) is reduction of Intraocular Pressure (IOP).

State-of-the-art Glaucoma Treatment at the touch of a button

The BELKIN Vision DSLT (Direct SLT) enables, with a press of a button, the delivery of a single laser beam with a pulse duration of a few nanoseconds, 120 times, in about a second while the eye remains free of contact. The laser beam is delivered to the limbus, behind which the drainage area of the eye – the trabecular meshwork (TM) - is located, enhancing intraocular fluid drainage, thus lowering the intraocular pressure, which is the main risk factor of glaucoma.

BELKIN Vision’s Differentiated Technology

  • Powered by sophisticated image acquisition and eye tracking algorithms
  • Real-time corrections detect eye movement enabling fast treatment

Welcome to the New Frontier of Glaucoma Treatment

Automated

Sophisticated
Technology

Extremely Quick

Treatment in
Seconds

Intuitive

No Special Expertise
Required

Patient Friendly

Non-Invasive
and Painless

ACG Solution

Exclusive Solution for
Angle Closure Glaucoma

BELKIN Vision’s technology is simple, intuitive, user-friendly and patient-friendly. It can be utilized in any clinic and hospital as an initial treatment for glaucoma, even prior to the use of eye drops, or in conjunction with eye drops.

Improves outcomes

  • Overcome the problem of low compliance associated with eye drop treatment
  • Transfer control of the treatment to the physician
  • Reduces the need for invasive treatment

BELKIN’s Laser Procedure

  • Can be repeated yearly according to need
  • Can be administered by any eye care practitioner – not just ophthalmologists
  • Treats BOTH Angle Closure Glaucoma and Open Angle Glaucoma
  • Provides an alternative to eye drops or can be used in conjunction reducing dependence on patient adherence

Exclusive Solution for Angle Closure Glaucoma

BELKIN’s innovative technology provides a solution for:

  • Open angle glaucoma (OAG)(70% of total glaucoma cases)
  • Angle closure glaucoma (ACG) (~30%) – commonly found among East Asian populations, especially in China.

BELKIN Vision’s device has the potential to treat ACG easily and simply. Laser beams are delivered through the external part of the eye, thus overcoming the challenge of visualizing the narrow angle.

The BELKIN Vision device offers an exclusive solution for ACG patients.

Glaucoma First-Line Treatment Alternatives

Intellectual Property

Skip to content